Georg Ledderose

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

H-J Kolb, J. Mittermüller, Ch. Clemm et al. · Blood · 1990 · 1.5K citations · Full text

Medicine, Hematology, Oncology +16

Sequential Regimen of Chemotherapy, Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation, and Prophylactic Donor Lymphocyte Transfusion in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Christoph Schmid, Michael Schleuning, Georg Ledderose et al. · Journal of Clinical Oncology · 2005 · 419 citations

Medicine, Oncology, Cell Therapy +15

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

Andreas Moosmann, Iris Bigalke, Johanna Tischer et al. · Blood · 2010 · 216 citations

Life Sciences, Immunology, Infectious Diseases +15

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

Michael Stadler, Martin Bornhäuser, Gesine Bug et al. · Blood · 2005 · 199 citations · Full text

Medicine, Molecular Biology, Oncology +13

Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)

Ernst Holler, HJ Kolb, J. Mittermüller et al. · Blood · 1995 · 195 citations · Full text

Life Sciences, Immunology, Immunoregulation +15